Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Natural Alternatives International ( (NAII) ) is now available.
Natural Alternatives International, Inc. announced that it failed to comply with certain financial covenants under its Credit Agreement with Wells Fargo Bank for its fiscal first quarter ending September 30, 2025. To address the issue, the company successfully negotiated a Waiver and Release Agreement with Wells Fargo on December 17, 2025, ensuring that all defaults were waived and the Credit Agreement remains fully operational. This resolution reinforces the company’s ability to maintain its financial arrangements and supports its ongoing operations, bringing stability for stakeholders moving forward.
The most recent analyst rating on (NAII) stock is a Hold with a $4.00 price target. To see the full list of analyst forecasts on Natural Alternatives International stock, see the NAII Stock Forecast page.
Spark’s Take on NAII Stock
According to Spark, TipRanks’ AI Analyst, NAII is a Neutral.
The overall stock score is primarily influenced by financial challenges, including declining profitability and cash flow issues, which are significant concerns. While technical analysis shows bullish momentum, the valuation suggests potential overvaluation. The absence of earnings call data and corporate events means these factors do not influence the score.
To see Spark’s full report on NAII stock, click here.
More about Natural Alternatives International
Natural Alternatives International, Inc. is a Delaware corporation operating in the health and wellness industry, specializing in nutritional supplement manufacturing and formulations.
Average Trading Volume: 24,253
Technical Sentiment Signal: Sell
Current Market Cap: $19.7M
See more data about NAII stock on TipRanks’ Stock Analysis page.

